Armata Pharmaceuticals, Inc.
ARMPNYSECIK 921114HealthcareFiscal year ends Dec 31
All transactions: 6
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2022-03-31 | Innoviva, Inc.Director, 10% owner | Purchase | 5,385,208 | $5.00 | $26.9m | Form 4 |
| 2022-02-09 | Innoviva, Inc.Director, 10% owner | Purchase | 3,614,792 | $5.00 | $18.1m | Form 4 |
| 2021-10-29 | Innoviva, Inc.Director, 10% owner | Purchase | 1,212,122 | $3.30 | $4.0m | Form 4 |
| 2021-03-17 | Innoviva, Inc.Director, 10% owner | Purchase | 4,285,935 | $3.25 | $13.9m | Form 4 |
| 2021-01-26 | Innoviva, Inc.Director, 10% owner | Purchase | 1,867,912 | $3.25 | $6.1m | Form 4 |
| 2020-03-27 | Innoviva, Inc.10% owner | Purchase | 7,717,661 | $2.87 | $22.1m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.